What factors should be considered when deciding between breastfeeding and Iluvien (fluocinolone acetonide) therapy?

The decision whether to discontinue breastfeeding or abstain from Iluvien (fluocinolone acetonide) therapy should weigh breastfeeding’s benefit for the child against therapy’s benefit for the woman, noting that systemic fluocinolone enters breast milk although exposure after intravitreal administration is expected to be very low.